Lexicon Pharmaceuticals, Inc. (LXRX) Net income 2016–2025
Lexicon Pharmaceuticals, Inc. (LXRX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$50.3MFY2025 · since FY2016: -$131.4M → -$50.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$50.3M | +74.9% |
| FY2024 | -$200.4M | -13.1% |
| FY2023 | -$177.1M | -73.7% |
| FY2022 | -$101.9M | -16.2% |
| FY2021 | -$87.8M | -49.8% |
| FY2020 | -$58.6M | -145.0% |
| FY2019 | $130.1M | +208.0% |
| FY2018 | -$120.5M | +2.0% |
| FY2017 | -$123.0M | +6.4% |
| FY2016 | -$131.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice